Catalyst Wire Dossier Catalyst Wire Dossier

VEGF-A165/bFGF plasmid

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VEGF-A165/bFGF plasmid, covering 2009-12-01 to 2009-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial [Phase 2]

See pricing